Plans within plans: post-transcriptional regulation governs macrophage responses. Mackenzie H Smith

Trends Immunol. 2025 Jun 30:S1471-4906(25)00142-5. doi: 10.1016/j.it.2025.06.001. Online ahead of print. ABSTRACT Macrophages are sentinels and first responders of the innate immune system. By sensing danger signals, they initiate and amplify inflammatory and regenerative cascades to control appropriate responses to pathogens and tissue damage. Transcriptional activation of macrophage gene expression has been studied extensively, but … Read more

Infusion of neutralization into Lassa vaccine design. Haoyang Li

Trends Immunol. 2025 Jun 23:S1471-4906(25)00141-3. doi: 10.1016/j.it.2025.05.006. Online ahead of print. ABSTRACT Lassa virus (LASV), which causes deadly Lassa fever (endemic in Western Africa), is a priority pathogen and a global health threat. Current vaccine candidates protect LASV-challenged animals through T cell immunity or non-neutralizing IgG/Fc receptor-mediated functions in the absence of potent neutralization. Neutralizing … Read more

Cryptic but critical: non-canonical antigens in cancer immunotherapy. Gabriel Goncalves

Trends Immunol. 2025 Jun 18:S1471-4906(25)00143-7. doi: 10.1016/j.it.2025.06.002. Online ahead of print. ABSTRACT Two recent studies, by Ely et al. and Apavaloaei et al., revealed that non-canonical antigens derived from unmutated, noncoding regions dominate the immunopeptidome of many cancers. Here, we discuss how this challenges conventional mutation-centric immunotherapies and highlight emerging strategies, including cryptic antigen- and … Read more

The T cell subsetting challenge. Natalia R Comet

Trends Immunol. 2025 Jun 16:S1471-4906(25)00140-1. doi: 10.1016/j.it.2025.05.005. Online ahead of print. ABSTRACT Exploiting specific T cell subset properties bears potential for T cell therapies but is complicated by inconsistencies in T cell subset definitions and markers. Here, we discuss causes for the definition and classification complexities to provide a handle for how to navigate the … Read more

Exploring mucosal immune development and function in utero. Madison S Strine

Trends Immunol. 2025 Jun 14:S1471-4906(25)00125-5. doi: 10.1016/j.it.2025.05.004. Online ahead of print. ABSTRACT Multiomics advances have led to breakthroughs in understanding human early life immunity. Adaptive memory immune cells have been detected in fetal tissue extremely early in gestation, where they may respond to maternal exposures. These promising findings lay the groundwork for future research on … Read more

A physiological perspective on neuroimmune tissue innervation. Daniel A Waizman

Trends Immunol. 2025 Jun 11:S1471-4906(25)00124-3. doi: 10.1016/j.it.2025.05.003. Online ahead of print. ABSTRACT Organisms must adapt to unpredictable environmental perturbations. We propose that the immune system, which can be redistributed across tissues (‘immune innervation’), cooperates with the nervous system to form a larger integrative network that can maximize the number of adaptive physiologic states to a … Read more

Restraining the killers: regulation of T cell quiescence. Molly E Lumnitzer

Trends Immunol. 2025 May 27:S1471-4906(25)00121-8. doi: 10.1016/j.it.2025.04.008. Online ahead of print. ABSTRACT Active regulation of T cell quiescence is important to sustain immune responses to vaccination and infection while preventing inappropriate responses such as autoimmunity. Recent studies highlight that quiescence in naïve T cells is actively regulated by transcription factors and tonic signaling. Loss of … Read more

Lactate trains immunity. Alba Llibre

Trends Immunol. 2025 May 26:S1471-4906(25)00123-1. doi: 10.1016/j.it.2025.05.002. Online ahead of print. ABSTRACT Understanding the mechanisms implicated in the establishment of trained immunity could aid the design of novel therapeutic approaches. By studying Bacille Calmette-Guerin (BCG) vaccination in a human cohort, Ziogas and colleagues demonstrate the role of lactate generation and its use for histone lactylation … Read more

Microglia replacement: from monocytic origin to therapy. Jingyi Yang

Trends Immunol. 2025 May 26:S1471-4906(25)00122-X. doi: 10.1016/j.it.2025.05.001. Online ahead of print. ABSTRACT Microglia replacement is reshaping neurodegenerative disease therapy, yet its key prerequisites remain unclear. In the current issue of Immunity, Aisenberg et al. and Bastos et al. reveal how developmental origin influences monocyte engraftment into the brain, and demonstrate the therapeutic potential of monocyte-based … Read more

YTHDF2: a key RNA reader and antitumor target. Sai Xiao

Trends Immunol. 2025 May 20:S1471-4906(25)00095-X. doi: 10.1016/j.it.2025.04.003. Online ahead of print. ABSTRACT N6-methyladenosine (m6A) is a key mRNA modification influencing mRNA stability and translation. YTHDF2, a major m6A ‘reader’, was initially recognized for promoting mRNA decay but is now also known to enhance translation by binding to methylated mRNAs. YTHDF2 maintains the function of immune … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri